# Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

> **NCT03887936** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 92 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Hypogonadism

## Interventions

- **DRUG:** Testosterone gel 1.62%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03887936
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2025-10-08
- **Final completion:** 2025-10-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03887936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03887936, "Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03887936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*